Bluejay Diagnostics Inc

NAS:BJDX (USA)  
$ 0.55 +0.0033 (+0.6%) 11:09 PM EST
At Loss
P/B:
0.24
Enterprise V:
$ -377.00K
Volume:
27.49K
Avg Vol (2M):
43.65K
Volume:
27.49K
At Loss
Avg Vol (2M):
43.65K

Business Description

Bluejay Diagnostics Inc
NAICS : 325413 SIC : 5047
ISIN : US0956333019
Description
Bluejay Diagnostics Inc is a medical diagnostics company. It is engaged in developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Name Current Vs Industry Vs History
Cash-To-Debt 6.26
Equity-to-Asset 0.6
Debt-to-Equity 0.12
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -78.2
3-Year EPS without NRI Growth Rate -67.9
3-Year FCF Growth Rate -117.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 17.31
9-Day RSI 20.33
14-Day RSI 24.35
6-1 Month Momentum % -79.72
12-1 Month Momentum % -88.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.82
Quick Ratio 1.82
Cash Ratio 1.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25
Shareholder Yield % -1.07
Name Current Vs Industry Vs History
ROE % -141.44
ROA % -108.19
ROIC % -488.58
ROC (Joel Greenblatt) % -521.07
ROCE % -141.11

Financials (Next Earnings Date:2024-05-10 Est.)

BJDX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BJDX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bluejay Diagnostics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -9.01
Beta 0
Volatility % 77.77
14-Day RSI 24.35
14-Day ATR ($) 0.070863
20-Day SMA ($) 0.695715
12-1 Month Momentum % -88.53
52-Week Range ($) 0.4703 - 13.9799
Shares Outstanding (Mil) 2.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bluejay Diagnostics Inc Filings

Filing Date Document Date Form
No Filing Data

Bluejay Diagnostics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Bluejay Diagnostics Inc Frequently Asked Questions

What is Bluejay Diagnostics Inc(BJDX)'s stock price today?
The current price of BJDX is $0.55. The 52 week high of BJDX is $13.98 and 52 week low is $0.47.
When is next earnings date of Bluejay Diagnostics Inc(BJDX)?
The next earnings date of Bluejay Diagnostics Inc(BJDX) is 2024-05-10 Est..
Does Bluejay Diagnostics Inc(BJDX) pay dividends? If so, how much?
Bluejay Diagnostics Inc(BJDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1